Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cipta Sarana Medika Tbk. (DKHH) vs Reksa Dana Indeks Simas ETF IDX30 (XSBC) Price & Performance

Cipta Sarana Medika Tbk.Trade
Reksa Dana Indeks Simas ETF IDX30Trade

Price performance (Past 24H)

Key statistics

Cipta Sarana Medika Tbk. vs Reksa Dana Indeks Simas ETF IDX30 — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 163.22B, 3.92M 24h volume), while Reksa Dana Indeks Simas ETF IDX30 trades at Rp90 (market cap 11.43B, 100 24h volume). The key difference: Cipta Sarana Medika Tbk. is far larger — about 14.3× Reksa Dana Indeks Simas ETF IDX30's market cap, and Cipta Sarana Medika Tbk. is more actively traded (3.92M versus 100). Which is the better fit depends on your goals.

DKHHXSBC
Market Cap
163.22B11.43B
Volume
3.92M100
Lot
39.16K1
Turnover
249.6M9K
Average Price
63.7490
Value
249.6M9K
Indicative Equilibrium Price
64
Indicative Equilibrium Volume
77

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DKHH
View details

About Cipta Sarana Medika Tbk.

PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.

Read more on DKHH

About Reksa Dana Indeks Simas ETF IDX30

Read more on XSBC